Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study

<div>Flow diagram of the study participants and outcomes (compliance subgroups). RSV, respiratory syncytial virus.</div>

Canadian Respiratory Journal

fig2

Figure 2

Figure 2: Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study 

Figure 2 | Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study 